Compound Monograph
Methylecgonidine
Methylecgonidine (anhydroecgonine methyl ester, AEME) is a tropane alkaloid with a double identity: a primary native alkaloid of coca seeds, and the characteristic pyrolysis product formed when cocaine base is smoked — making it both a forensic marker of smoked-cocaine exposure and a suspected contributor to its cardiorespiratory and neuro-toxicity.
Sources · 3
Where Does It Come From?
Methylecgonidine is a naturally occurring tropane alkaloid (anhydroecgonine ester), found in Coca seed and 2 other sources. It is flagged as toxic.
Concentration
Content by Source
Concentrations not reported. No percent-dry-weight or mg/g figures have been published for this compound in its source plants.
Methylecgonidine at a Glance
Methylecgonidine — more formally anhydroecgonine methyl ester (AEME) — is a small tropane alkaloid built on the same ecgonine skeleton as cocaine, but lacking cocaine’s benzoyl group. It is best understood through its double identity: it is a genuine natural alkaloid of the coca seed, and, quite separately, it is the signature product formed when cocaine base is pyrolysed (smoked) 1,
That second identity is why the molecule matters clinically and forensically. Because AEME is generated by heat and is largely absent from cocaine taken by other routes, its presence in blood, urine or hair is used as a biomarker of smoked-cocaine exposure 7,
This page treats AEME as a phytochemistry and toxicology entry. It covers what the molecule is, where it genuinely occurs in the plant, and what the toxicology literature reports — with no description of how cocaine is prepared or smoked.
The Seed Alkaloid That Is Also The Smoked-Cocaine Marker
Two threads define this molecule, and keeping them separate is the whole point of the page.
Thread one — a true coca-seed alkaloid. When the alkaloids of Erythroxylum coca var. coca seeds were profiled, methylecgonidine was found to be the primary constituent of the seed, and specifically not an analytical artefact of the extraction 1Reference 1Alkaloid content of the seeds from Erythroxylum coca var. cocaView study →. This is an important and easily-missed distinction: AEME is often assumed to exist only as a decomposition product, but in coca seed it is a native alkaloid. Note that this is the seed, not the chewed leaf — the seed alkaloid profile differs from the consumed leaf, where cocaine dominates and AEME is at most a trace component.
Thread two — the smoked-cocaine pyrolysis marker. Separately and far more consequentially for public health, AEME forms when cocaine base is heated and inhaled: thermal elimination of benzoic acid from cocaine yields anhydroecgonine methyl ester in the smoke 7Reference 7Gas chromatographic-mass spectrometric detection of anhydroecgonine methyl ester (methylecgonidine) in human serum as evidence of recent smoking of crackView study →. Because it is produced by heat and appears in body fluids after smoking but little or not at all after intravenous or intranasal cocaine, AEME (and its downstream hydrolysis product anhydroecgonine) serve as forensic biomarkers that distinguish smoking from other routes of cocaine use 7,
The reason toxicologists care about the marker being present — rather than treating it as a passive tracer — is that AEME is pharmacologically active in its own right, and by a different mechanism than cocaine. Where cocaine acts on monoamine transporters and sodium channels, AEME acts on muscarinic acetylcholine receptors, and is a suspected contributor to the cardiorespiratory and neurological toxicity that is worse with smoked cocaine than with other routes 2,
What It's Used For
The evidence base is small, almost entirely animal and in-vitro, and centres on two questions: is AEME a reliable marker of smoked cocaine (a forensic-analytical question, well answered in humans), and does it contribute independently to toxicity (a mechanistic question, answered so far only in cells and animals).
Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. The forensic-marker row rests on human data; the toxicity rows are preclinical, so read the per-row basis.
The best-evidenced application, and the only one resting on human data. AEME is generated by pyrolysis of cocaine base and is therefore a route-specific marker: subjects who smoked cocaine excreted substantial AEME, while little or none appeared after intravenous or intranasal cocaine 8Reference 8Testing human hair and urine for anhydroecgonine methyl ester, a pyrolysis product of cocaineView study →.
It has been measured directly in human serum (reported ~3–34 ng/mL shortly after smoking) as evidence of recent crack use 7Reference 7Gas chromatographic-mass spectrometric detection of anhydroecgonine methyl ester (methylecgonidine) in human serum as evidence of recent smoking of crackView study →, and in hair (~0.2–2.4 ng/mg) and urine (~4–226 ng/mL) in casework populations 8Reference 8Testing human hair and urine for anhydroecgonine methyl ester, a pyrolysis product of cocaineView study →.
In the body AEME is hydrolysed — largely by butyrylcholinesterase — to anhydroecgonine, a second, longer-lived smoking marker 6,
This is analytical toxicology on the isolated molecule, not a health claim.
Gap: biomarker performance varies with sample matrix, timing and the fast clearance of AEME itself (see Pharmacokinetics); it confirms route, not dose or harm.
In cultured rat hippocampal neurons, AEME showed greater neurotoxic potential than cocaine after 24–48 h, and combining the two produced an additive loss of neuronal viability — a finding used to argue that smoking cocaine carries a higher neurotoxic risk than the parent drug alone 3Reference 3RCTNeurotoxicity of anhydroecgonine methyl ester, a crack cocaine pyrolysis productView study →.
Mechanistically, the toxicity is muscarinic: AEME acts as a partial agonist at M1 and M3 receptors, raises inositol phosphate and intracellular calcium, fragments DNA and activates caspase-driven apoptosis, and the cell death is blocked by atropine and by M1/M3 antagonism 4Reference 4RCTM1 and M3 muscarinic receptors may play a role in the neurotoxicity of anhydroecgonine methyl ester, a cocaine pyrolysis productView study →.
A 2024 systematic review synthesises these signals — muscarinic partial agonism, reactive-oxygen-species generation, glutathione imbalance and apoptosis — as AEME’s own contribution to cocaine toxicity 6Reference 6Systematic reviewToxicology of anhydroecgonine methyl ester: a systematic review of a cocaine pyrolysis productView study →.
In a separate model AEME did not itself cause behavioural sensitisation but potentiated cocaine’s locomotor and striatal-dopamine effects 5Reference 5RCTAnhydroecgonine methyl ester, a cocaine pyrolysis product, may contribute to cocaine behavioral sensitizationView study →.
Gap: entirely in-vitro / rodent; no human neurotoxicity outcome has been attributed to AEME specifically, and cell concentrations may not map onto real smoked exposure.
The cardiovascular signature is the clearest illustration that AEME is not a cocaine mimic. Given intravenously to sheep, methylecgonidine produced significant hypotension and tachycardia, and atropine pre-treatment abolished the hypotension — direct in-vivo evidence that AEME acts as a muscarinic agonist, the near-opposite of cocaine’s pressor, sympathomimetic effect 2Reference 2Pharmacokinetics and pharmacodynamics of methylecgonidine, a crack cocaine pyrolyzateView study →.
Consistent in-vitro work reports muscarinic actions on cardiac tissue (reduced contractility, nitric-oxide stimulation) and bronchoconstrictor / adverse inotropic effects, feeding the hypothesis that AEME contributes to the pulmonary and cardiac harms seen with smoked cocaine 2,
Gap: the direct cardiorespiratory data are animal and tissue-level; the human contribution of AEME to smoked-cocaine cardiotoxicity is inferred, not measured, and is confounded by cocaine co-exposure.
Mechanisms
| Target / pathway | Effect | Relevant to |
|---|---|---|
| M1 / M3 muscarinic acetylcholine receptors | partial agonism → raised inositol phosphate & intracellular calcium; atropine-reversible | neurotoxicity; cardiorespiratory toxicity |
| Other muscarinic subtypes | antagonist activity reported in calcium-mobilisation assays | mixed cholinergic profile |
| Cardiac muscarinic signalling | reduced contractility, nitric-oxide stimulation, hypotension + tachycardia in vivo | cardiotoxicity |
| Airway smooth muscle | bronchoconstriction (cholinergic) | pulmonary toxicity |
| Reactive oxygen species / glutathione system | oxidative stress, antioxidant-enzyme imbalance | neurotoxicity |
| Caspase-driven apoptosis / DNA fragmentation | programmed neuronal cell death after ~24 h exposure | neurotoxicity |
| Butyrylcholinesterase | hydrolyses AEME → anhydroecgonine (second smoking marker) | pharmacokinetics; biomarker |
The load-bearing point: AEME’s toxicity runs through the cholinergic/muscarinic system, which is mechanistically distinct from cocaine’s monoamine-reuptake and sodium-channel actions — so it adds a different flavour of harm rather than simply more cocaine.
Pharmacokinetics
Methylecgonidine is cleared quickly: in sheep its blood half-life was ~18–21 minutes, while its hydrolysis product anhydroecgonine persisted much longer (~94–137 minutes) 2Reference 2Pharmacokinetics and pharmacodynamics of methylecgonidine, a crack cocaine pyrolyzateView study →. In humans, AEME is hydrolysed by butyrylcholinesterase and by non-enzymatic processes to anhydroecgonine, so the pair is used together as smoking markers, with the longer-lived metabolite widening the detection window 6,
Clinical Trials
There are no therapeutic clinical trials of methylecgonidine — it is a toxicant and a forensic marker, not a candidate drug. The human literature is analytical-toxicology (biomarker detection in serum, urine and hair) 7,
| Completed | Planned | Terminated | Preclinical |
|---|---|---|---|
| Human biomarker detection studies (serum/urine/hair) | — | — | Muscarinic neurotoxicity, cardiorespiratory & behavioural-sensitisation models |
Last checked: July 2026.
Isolate vs. Plant Studies
Almost the entire literature concerns the isolated molecule, not a plant extract — appropriately, because the health-relevant exposure is not botanical. The neurotoxicity, muscarinic-agonism and cardiovascular studies all dose pure AEME (or AEME with pure cocaine) in cells and animals 2,
Prevalence in Nature
In the plant kingdom methylecgonidine is effectively confined to the genus Erythroxylum. Its documented natural occurrence is as the primary alkaloid of Erythroxylum coca var. coca seeds, where careful analysis established it as a true constituent rather than a breakdown product formed during extraction 1Reference 1Alkaloid content of the seeds from Erythroxylum coca var. cocaView study →. It sits within the coca tropane-alkaloid family alongside cocaine, cinnamoylcocaine, benzoylecgonine, ecgonine methyl ester and ecgonine — but unlike cocaine, which concentrates in the leaf (~0.5–1% dry weight of the consumed part), AEME’s native abundance is a seed phenomenon and is not quantified here as a leaf content. Its far larger real-world presence is non-botanical: as a component of smoked-cocaine smoke 7Reference 7Gas chromatographic-mass spectrometric detection of anhydroecgonine methyl ester (methylecgonidine) in human serum as evidence of recent smoking of crackView study →. See the coca monograph — /herb/coca — for the leaf’s alkaloid profile.
Discovery & Synthesis
Methylecgonidine entered the scientific record chiefly through forensic toxicology, where it was characterised from the 1990s onward as the marker that betrays smoked cocaine: work by Kintz and colleagues detected it in human hair and urine 8Reference 8Testing human hair and urine for anhydroecgonine methyl ester, a pyrolysis product of cocaineView study →, and Toennes and colleagues demonstrated it in human serum as evidence of recent crack smoking 7Reference 7Gas chromatographic-mass spectrometric detection of anhydroecgonine methyl ester (methylecgonidine) in human serum as evidence of recent smoking of crackView study →. Its status as a genuine native alkaloid — as opposed to purely a degradation product — was established for coca seed by Casale, Toske and Colley in 2005 1Reference 1Alkaloid content of the seeds from Erythroxylum coca var. cocaView study →. Chemically the molecule is anhydroecgonine methyl ester: it corresponds to cocaine that has lost its benzoic-acid group, and it is this thermal elimination of benzoic acid from cocaine that generates AEME in smoke 7Reference 7Gas chromatographic-mass spectrometric detection of anhydroecgonine methyl ester (methylecgonidine) in human serum as evidence of recent smoking of crackView study →. Consistent with the sensitivity of this molecule, no preparation, extraction or synthesis procedure. Manufacture of AEME today is essentially limited to certified analytical reference standards for toxicology laboratories.
Patents: not yet researched.
Toxicity & Safety
Methylecgonidine carries a toxic flag. The rationale is not its trace natural occurrence in coca seed but its toxicological profile as a smoked-cocaine pyrolysis product: in preclinical models it is more neurotoxic than cocaine, acts as a muscarinic agonist with adverse cardiac and bronchoconstrictor effects, and drives oxidative stress and apoptosis 2,
- A suspected independent toxicant in smoked cocaine. In cells AEME is more neurotoxic than cocaine and additive with it; it drives muscarinic signalling, oxidative stress and apoptosis 3,
6Reference 3RCTNeurotoxicity of anhydroecgonine methyl ester, a crack cocaine pyrolysis productView study →Reference 6Systematic reviewToxicology of anhydroecgonine methyl ester: a systematic review of a cocaine pyrolysis productView study → . - Muscarinic cardiorespiratory effects. In vivo it causes atropine-reversible hypotension and tachycardia, with in-vitro bronchoconstriction and reduced cardiac contractility — a cholinergic profile unlike cocaine’s 2,
4Reference 2Pharmacokinetics and pharmacodynamics of methylecgonidine, a crack cocaine pyrolyzateView study →Reference 4RCTM1 and M3 muscarinic receptors may play a role in the neurotoxicity of anhydroecgonine methyl ester, a cocaine pyrolysis productView study → . - A marker of exposure, not a benign one. Its detection confirms smoked-cocaine exposure; the same routes that create the marker create the toxicity 7,
8Reference 7Gas chromatographic-mass spectrometric detection of anhydroecgonine methyl ester (methylecgonidine) in human serum as evidence of recent smoking of crackView study →Reference 8Testing human hair and urine for anhydroecgonine methyl ester, a pyrolysis product of cocaineView study → . - Negligible dietary/botanical exposure. Native AEME is confined to coca seed, not the consumed leaf, so ordinary botanical exposure is trivial — the toxicity story is about the pyrolysis product, not the plant.
Dosage
There is no dose for methylecgonidine. It is not an ingested herb, supplement or medicine; it has no established human therapeutic use; and its real-world exposure is involuntary, as a component of smoked-cocaine smoke. The concentration figures cited here (serum, urine and hair levels) are forensic biomarker measurements, not doses, and are reported only to characterise the molecule. Nothing here is a personal recommendation.
References
- Casale JF, Toske SG, Colley VL (2005). Alkaloid content of the seeds from Erythroxylum coca var. coca. Journal of Forensic Sciences. https://pubmed.ncbi.nlm.nih.gov/16382835/
- Scheidweiler KB, Plessinger MA, Shojaie J, Wood RW, Kwong TC (2003). Pharmacokinetics and pharmacodynamics of methylecgonidine, a crack cocaine pyrolyzate. Journal of Pharmacology and Experimental Therapeutics. https://pubmed.ncbi.nlm.nih.gov/14561847/
- Garcia RCT, et al. (2012). Neurotoxicity of anhydroecgonine methyl ester, a crack cocaine pyrolysis product. Toxicological Sciences. https://pubmed.ncbi.nlm.nih.gov/22523227/
- Garcia RCT, et al. (2015). M1 and M3 muscarinic receptors may play a role in the neurotoxicity of anhydroecgonine methyl ester, a cocaine pyrolysis product. Scientific Reports. https://pubmed.ncbi.nlm.nih.gov/26626425/
- Garcia RCT, et al. (2017). Anhydroecgonine methyl ester, a cocaine pyrolysis product, may contribute to cocaine behavioral sensitization. Toxicology. https://pubmed.ncbi.nlm.nih.gov/27129946/
- Romero-Noreña A, Contreras-Martinez HJ, Mendivil-Perez M (2024). Toxicology of anhydroecgonine methyl ester: a systematic review of a cocaine pyrolysis product. Toxicology Reports. https://pubmed.ncbi.nlm.nih.gov/39104366/
- Toennes SW, Fandiño AS, Kauert G (1999). Gas chromatographic-mass spectrometric detection of anhydroecgonine methyl ester (methylecgonidine) in human serum as evidence of recent smoking of crack. Journal of Chromatography B: Biomedical Sciences and Applications. https://pubmed.ncbi.nlm.nih.gov/10630898/
- Kintz P, Cirimele V, Sengler C, Mangin P (1995). Testing human hair and urine for anhydroecgonine methyl ester, a pyrolysis product of cocaine. Journal of Analytical Toxicology. https://pubmed.ncbi.nlm.nih.gov/8926742/
